1-3 of 3
Yanyu Wu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Cost-Effectiveness Model of Recombinant FVIII Versus Emicizumab Treatment of Patients With Severe Hemophilia A Without Inhibitors

Shawn X. Sun, Yanyu Wu, Michael McDermott, Marjolijn van Keep
Journal: Blood
Blood (2019) 134 (Supplement_1): 2102.
https://doi.org/10.1182/blood-2019-124421
Published: 2019
Journal Articles

Estimation of the Economic Burden Associated with Major Surgery Due to Von Willebrand Disease Based on Claims Data from the USA

Abiola Oladapo, Yanyu Wu, Mei Lu, Sepehr Farahbakhshian, Bruce Ewenstein
Journal: Blood
Blood (2019) 134 (Supplement_1): 4692.
https://doi.org/10.1182/blood-2019-122749
Published: 2019
Journal Articles

Prevalence and Burden of Major Bleeding Events in Patients with Von Willebrand Disease Based on Claims Data from the USA

Mei Lu, MD MSc, Abiola Oladapo, PhD MSc, BPharm, Yanyu Wu, BA, MS, PhD, Sepehr Farahbakhshian, BSc, MSc, Bruce Ewenstein, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2222.
https://doi.org/10.1182/blood-2018-99-113293
Published: 2018